Quadria's oversubscribed fund: What it signals for Asia's healthcare industry
'It reflects the strong global investor confidence in the transformational opportunity within Asian healthcare, where social impact and financial performance go hand in hand,' confirms Abrar Mir, co-founder and managing partner at Quadria Capital.
Quadria Capital said in a statement on Tuesday that Fund III drew support from prominent sovereign wealth funds, asset managers, and strategic corporates across North America and Europe. It also secured new commitments from globally recognised institutional investors, with notable participation from leading institutions in the GCC—including Saudi Arabia, the UAE, and Bahrain.
In India, the Fund attracted new capital from major banks, insurance companies, and family offices. Additionally, robust re-up commitments from impact investors reaffirm Quadria's dedication to building scalable, high-impact healthcare businesses that deliver lifesaving care to underserved populations across Asia.
Asian Healthcare Scenario
Currently Asia's healthcare market is estimated to be $5 trillion, and the healthcare industry is reportedly at a pivotal inflection point and will remain a focal area into 2025.
"In India, particularly, we're seeing significant investment interest in single-specialty hospitals, diagnostics, medical devices, and pharmaceutical manufacturing—including active pharma ingredients (APIs) and contract (drug) development and manufacturing (CDM). These segments are poised for growth due to increasing healthcare consumption, cost-efficiency initiatives, and deeper technology integration," says Dr Amit Verma, co-founder and managing partner, Quadria Capital.
Healthcare growth funds like Quadria's typically provide the industry with strategic guidance and operational support to help scale their businesses and achieve market leadership.
Quadria claims that nearly 40% of Fund III is already deployed. Its current investments include Aragen Life Sciences (a global CRDMO serving 400+ pharmaceutical clients), NephroPlus (Asia's largest dialysis chain), and Maxivision (India's leading eye care chain). Two new investments in Southeast Asia are expected shortly, it says.
India Impact
India is rapidly emerging as a strategic hub for global pharmaceutical and MedTech manufacturing as supply chains diversify, especially with the China plus strategy.
While the per capita healthcare spending in India remains low at just $74—far below regional peers like Thailand (US$364) and Malaysia (US$487)—with nearly 50% of healthcare costs still paid out-of-pocket, the healthcare focused funds can catalyse Indian healthcare innovation by strategically investing in high-growth areas such as specialised care and pharmaceutical manufacturing, aiming to create scalable, affordable healthcare solutions for over a billion people.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
27 minutes ago
- NDTV
Honda Cars India's Total Wholesale In May'25 Stood At 5,985 Units
Honda Cars India Ltd. (HCIL), registered total sales of 5,985 units in May'25. Domestic sales of the company stood at 3,950 units and exports at 2,035 units. Sharing thoughts on the sales performance, Mr. Kunal Behl, Vice President, Marketing & Sales, Honda Cars India Ltd. said, "In view of the prevailing market conditions and subdued consumer sentiment, we continued to strategically moderate our dispatches in May to maintain optimal inventory levels across our network, while remaining optimistic about improved retail performance in the coming months supported by forecasts of a better monsoon." In the corresponding month last year, the Japanese marque retailed 4,822 units in the Indian market, while the export figures stood at 6,521 units. Besides, the new helmsman, Takashi Nakajima, who recently took over as the president and CEO of the company from Takuya Tsumura, made a slew of announcements at an informal event in Delhi. One of the highlights was the confirmation of the launch of a new battery electric vehicle (BEV) in the next fiscal year. It will not be based on the Honda Elevate, as speculated earlier, but instead it will be an EV made specifically for the Indian market. Honda hasn't made it clear whether the new EV will be an SUV or a sedan, but sources suggest that it is likely to be SUV, that could go up against the likes of the Maruti Suzuki e-Vitara, Hyundai Creta EV, Tata Curvv EV and so on. The company believes in having a different brand strategy for ICE and electric vehicles, unlike some other brands which opt for the same/similar branding. Honda is also silently working on its charging infrastructure, so that when the new EV arrives, the support network will be ready.
Business Standard
28 minutes ago
- Business Standard
Schloss Bangalore (The Leela) slides on debut
Shares of Schloss Bangalore (The Leela) were currently trading at Rs 424.90 at 10:20 IST on the BSE, representing a discount of 2.32% compared with the issue price of Rs 435. The scrip was listed at Rs 406.50, exhibiting a discount of 6.55% to the issue price. So far, the stock has hit a high of 426.90 and a low of 404.45. On the BSE, over 2.60 lakh shares of the company were traded in the counter so far. The initial public offer (IPO) of Schloss Bangalore (The Leela) was subscribed 4.50 times. The issue opened for bidding on Monday, 26 May 2025 and it closed on Wednesday, 28 May 2025. The price band of the IPO is fixed between Rs 413 and 435 per share. The IPO consisted of a fresh issue of Rs 2500 crore and an offer-for-sale (OFS) of up to Rs 1,000 crore. At the higher price band of Rs 435, the OFS comprises up to 5,74,71,264 shares by Project Ballet Bangalore Holdings (DIFC) Pvt Ltd. Out of the proceeds from the fresh issue, Rs 2300 crore will be used for repayment/prepayment/redemption, in full or in part, of certain borrowings availed of by the company and its subsidiaries, and the balance for general corporate purposes. Ahead of the IPO, Schloss Bangalore (The Leela) on Friday, 23 May 2025, raised Rs 1,574.99 crore from anchor investors. The board allotted 3,62,06,896 shares at Rs 435 each to 47 anchor investors. Schloss Bangalore (The Leela) is a luxury hospitality company operating under "The Leela" brand in India. It owns, operates, manages, and develops luxury hotels and resorts, offering premier accommodations and personalized services inspired by Indian hospitality. The owned portfolio comprises five landmark hotels across key business and leisure destinations: Bengaluru, Chennai, New Delhi, Jaipur, and Udaipur. For the financial year 2025, the company derived 56.96% of its room revenues from retail and leisure guests, 16.97% from corporate bookings, and 25.45% from group bookings, demonstrating the strength of the diversified customer base. As of March 31, 2025, Schloss Bangalore is one of Indias largest luxury hospitality companies by number of keys, with a portfolio of 13 operational hotels comprising 3,553 keys. The portfolio includes The Leela Palaces, The Leela Hotels, and The Leela Resorts. The company operates through direct ownership and hotel management agreements with third-party owners. The firm reported a consolidated net profit of Rs 47.66 crore and revenue from operations of Rs 1,300.57 crore for the financial year 2024-25.
Mint
38 minutes ago
- Mint
Top personal loan offers for government employees in India – June 2025 rates compared
Most Indian government employees are in a unique financial position when it comes to personal loans. Banks and other financial institutions are offering them specially designed loan products and with incredibly favourable terms because of their annual salary, employment and reliable sources of income. This article will outline the various benefits that may be available, interest rates, and some important considerations for personal loans for government employees. Since government employees have both regular and secure sources of income, they are often viewed as a less risky borrower by lenders. Because of this, lenders may be able to offer government employees better credit terms, rates, and higher limits on their personal loans. Loan amount: Personal loans for government employees may range from ₹ 50,000 minimum to ₹ 55 lakh maximum, depending on the lender and the applicant's profile. Personal loans for government employees may range from 50,000 minimum to 55 lakh maximum, depending on the lender and the applicant's profile. Repayment: To borrow the full potential of any loan, payments to repay the loan can be chosen to be available. To borrow the full potential of any loan, payments to repay the loan can be chosen to be available. Minimal documentation: The process for loans for government employees is generally simple and uncomplicated. There is limited documentation for the loan application like identity proof and address proof, as well as pay slips. The process for loans for government employees is generally simple and uncomplicated. There is limited documentation for the loan application like identity proof and address proof, as well as pay slips. Fast approval: In some instances, lenders can approve the application, payment confirmation, and the disbursal of funds all in the same day - being less than 24 hours after the funds have been confirmed based on an approved application. The typical eligibility requirements include some of the following, but individual restrictions may vary from lenders to lender: Age: Generally between 21 and 60. Employment: Long-standing government employment; at least a year of concurrent employment is often desired. Income: A minimum level of monthly income for eligibility, often starting from ₹ 25,000. Credit score: A higher credit score, often 750 and above, enhances chances of being approved for a loan. Banks Interest rates SBI 10.30% Union Bank 10.60% ICICI Bank 10.85% HDFC Bank 10.90% Kotak Mahindra Bank 10.99% PNB 11.00% Axis Bank 11.25% IDBI Bank 12.9% Compare offers: Compare the loan offers of several lenders to find the best possible interest rate and terms. Compare the loan offers of several lenders to find the best possible interest rate and terms. Assess repayment capacity: Assess repayment capacity using an EMI calculator to establish your repayment schedule and understand the monthly repayment you're comfortable with. Assess repayment capacity using an EMI calculator to establish your repayment schedule and understand the monthly repayment you're comfortable with. Maintain high credit score: Because the higher credit score provides better terms on loans. Because the higher credit score provides better terms on loans. Review and understand the small print: Ensure to check all terms and conditions. Do any have an early repayment penalty or extra fees. In conclusion, using personal loans for government employees comes with many advantages. Including lower interest rates, bigger loan amounts and the option of flexible repayment schedules. With the knowledge of their options, and knowing their financial situations, government employees are able to make educated decisions in supporting their personal financial objectives. Disclaimer:Mint has a tie-up with fin-techs for providing credit, you will need to share your information if you apply. These tie-ups do not influence our editorial content. This article only intends to educate and spread awareness about credit needs like loans, credit cards and credit score. Mint does not promote or encourage taking credit as it comes with a set of risks such as high interest rates, hidden charges, etc. We advise investors to discuss with certified experts before taking any credit.
